The most common brand name prescription drugs used by older Americans escalated sharply in price in 2015, as they have in much of the past decade, according to a new AARP report.

AARP’s researchers examined prices for 268 brand name drugs that cover common conditions such as diabetes, hypertension and high cholesterol that are often chronic. They found those prices on average rose 15.5 percent last year (compared to a general inflation rate of 0.1 percent), as outlined in the association’s “RX Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans, 2006-2015.”

The average older American takes 4.5 prescription drugs per month, the report notes. Beneficiaries are typically not responsible for all of the costs, but increases can still impact them.

“This new report once again highlights the high and unrelenting price increases that are shockingly common in the pharmaceutical market,” AARP’s chief public policy officer, Debra Whitman, said in a statement. “What’s particularly remarkable is that these incredibly high price increases are still occurring in the face of the intense public and congressional criticism of prescription drug pricing practices.”

Advertise with us

The report states that retail prices increased for 97 percent of the 268 brand name prescriptions reviewed, with seven that are widely used increasing more than 50 percent in cost in 2015.

AARP noted that even if people have good health care coverage that helps them avoid bearing the full impact, the price increases could result in their paying higher premiums, deductibles and other out-of-pocket costs, especially if their plan calls for them to cover a percentage of drug costs rather than a fixed co-payment.

Gary Rotstein: grotstein@post-gazette.com or 412-263-1255.